Abstract

ObjectiveTo assess the effect of comedication with conventional synthetic disease modifying antirheumatic drugs (csDMARDs) on retention to tumour necrosis factor inhibitor (TNFi) therapy in patients with ankylosing spondylitis (AS) and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
OP0237 INTERLEUKIN-17 OR TNF BLOCKADE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AFTER WITHDRAWAL OF AT LEAST ONE TNF INHIBITOR
Adrian Ciurea ... Almut Scherer
-
Adrian Ciurea, et. al.Adrian Ciurea ... Almut Scherer
01 Jun 2019
Conventional Synthetic Dmards in Psoriatic Arthritis: Changing Practice in Biologic Era; Real-Life Results from HURBIO-PsA Registry
Emre Bilgin ... Umut Kalyoncu
Acta Medica | VOL. -
Emre Bilgin, et. al.Emre Bilgin ... Umut Kalyoncu
16 Nov 2021
SAT0297 The role of baseline concomitant use of conventional synthetic disease modifying anti-rheumatic drugs with tnf inhibitors in spondyloarthritis patients
...
Annals of the Rheumatic Diseases | VOL. 77
, et. al. ...
01 Jun 2018
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice
Tor Olofsson ... Ilia Qirjazo
Arthritis Research & Therapy | VOL. 21
Tor Olofsson, et. al.Tor Olofsson ... Ilia Qirjazo
28 May 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis
Mengqi Huang ... Robert Lafyatis
Annals of the Rheumatic Diseases | VOL. -
Mengqi Huang, et. al.Mengqi Huang ... Robert Lafyatis
16 May 2024
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Megan R W Barber ... Ann E Clarke
Annals of the Rheumatic Diseases | VOL. -
Megan R W Barber, et. al.Megan R W Barber ... Ann E Clarke
16 May 2024
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
M Grace Hren ... Saakshi Khattri
Annals of the Rheumatic Diseases | VOL. -
M Grace Hren, et. al.M Grace Hren ... Saakshi Khattri
16 May 2024
News from EULAR
Yuliia Caliskan
Annals of the Rheumatic Diseases | VOL. 83
Yuliia CaliskanYuliia Caliskan
15 May 2024
View more papers